|
|
|
Volumn 32, Issue 3, 2005, Pages 292-296
|
|
Current and new therapeutic strategies in acute myeloid leukemia
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
4 (6 METHOXY 7 (3 PIPERIDIN 1 YLPROPOXY)QUINAZOLIN 4 YL)PIPERAZINE 1 CARBOXYLIC ACID (4 ISOPROPOXYPHENYL)AMIDE;
4-(6-METHOXY-7-(3-PIPERIDIN-1-YLPROPOXY)QUINAZOLIN-4-YL)PIPERAZINE-1-CARBOXYLIC ACID (4-ISOPROPOXYPHENYL)AMIDE;
AMINOGLYCOSIDE;
ANTINEOPLASTIC AGENT;
CARBAZOLE DERIVATIVE;
CD135 ANTIGEN;
CEP 701;
CYTARABINE;
DRUG DERIVATIVE;
ETOPOSIDE;
FLT3 PROTEIN, HUMAN;
FLT3 PROTEIN, MOUSE;
FLUDARABINE;
GEMTUZUMAB;
GRANULOCYTE COLONY STIMULATING FACTOR;
INDOLE DERIVATIVE;
MAV PROTOCOL;
MITOXANTRONE;
MONOCLONAL ANTIBODY;
ONCOPROTEIN;
PIPERAZINE DERIVATIVE;
PROTEIN TYROSINE KINASE;
QUINAZOLINE DERIVATIVE;
VIDARABINE;
ACUTE DISEASE;
ANIMAL;
DISEASE FREE SURVIVAL;
DRUG ANTAGONISM;
HUMAN;
MIDDLE AGED;
MOUSE;
MYELOID LEUKEMIA;
PROGNOSIS;
REVIEW;
ACUTE DISEASE;
AMINOGLYCOSIDES;
ANIMALS;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARBAZOLES;
CYTARABINE;
DISEASE-FREE SURVIVAL;
ETOPOSIDE;
FMS-LIKE TYROSINE KINASE 3;
GRANULOCYTE COLONY-STIMULATING FACTOR;
HUMANS;
INDOLES;
LEUKEMIA, MYELOID;
MICE;
MIDDLE AGED;
MITOXANTRONE;
PIPERAZINES;
PROGNOSIS;
PROTO-ONCOGENE PROTEINS;
QUINAZOLINES;
RECEPTOR PROTEIN-TYROSINE KINASES;
VIDARABINE;
|
|
EID: 15544363222
PISSN: 03850684
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (5)
|
|
References (8)
|
